Chemfab Alkalis

₹608.1 7 | 1.2%

WEBSITE BSE:541269 NSE : CHEMFABALKA 18 May, 12:50

Market Cap ₹865 Cr.

Stock P/E 23.9

P/B 2.3

Current Price ₹608.1

Book Value ₹ 267.8

Face Value 10

52W High ₹742.7

Dividend Yield 0.21%

52W Low ₹ 285.1

Edit Ratio

Chemfab Alkalis Research see more...

Overview Inc. Year: Industry: Chemicals

Chemfab Alkalis Ltd manufactures and sells inorganic chemical substances in India and across the world. It operates through PVC-O Pipes segments and Chemicals and Related Products/Services. It offers caustic soda lye and flakes, liquid chlorine, hydrogen gas, hydrochloric acid, and sodium hypochlorite/bleach liquor merchandise, as well as commercial grade and suitable for eating salt products. The corporation was previously called Teamec Chlorates Ltd and changed its name to Chemfab Alkalis Ltd in July 2017. Chemfab Alkalis Ltd was founded in 1985 and is based in Chennai, India.

Chemfab Alkalis Share Price

New

Volume

Price

Price: NSE50 DMA200 DMAVolume

Quarterly Price

Quarterly Monthly

Show Value Show %

Peer Comparison

Chemfab Alkalis Quarterly Results

#(Fig in Cr.)	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023
Net Sales	59	78	88	98	76	84	73	79	80	86
Other Income	0	1	3	1	1	2	2	4	1	2
Total Income	59	78	91	99	77	86	75	83	81	88
Total Expenditure	52	55	69	63	50	59	49	64	69	71
Operating Profit	7	23	22	36	27	27	26	19	12	17
Interest	0	0	0	0	0	0	0	0	0	0
Depreciation	5	6	6	6	6	6	5	5	6	5
Exceptional Income / Expenses	0	0	0	0	-3	0	0	0	0	0
Profit Before Tax	1	17	16	30	18	21	21	14	7	11
Provision for Tax	0	5	4	9	5	6	5	4	2	4
Profit After Tax	1	12	13	21	13	15	15	10	4	7
Adjustments	0	0	0	-0	0	-0	0	0	-0	0
Profit After Adjustments	1	12	13	21	13	15	15	10	4	7
Adjusted Earnings Per Share	0.6	8.6	9.1	15.1	9.2	10.6	10.8	6.7	3	5

Chemfab Alkalis Profit & Loss

#(Fig in Cr.)	Mar 2020	Mar 2021	Mar 2022	Mar 2023	TTM
Net Sales	205	181	272	331	318
Other Income	3	1	6	6	9
Total Income	208	182	277	337	327
Total Expenditure	149	157	215	221	253
Operating Profit	59	25	62	116	74
Interest	4	3	1	1	0
Depreciation	25	20	22	23	21
Exceptional Income / Expenses	-3	0	0	-3	0
Profit Before Tax	27	2	39	89	53
Provision for Tax	1	10	10	25	15
Profit After Tax	25	-8	29	65	36
Adjustments	0	0	0	0	0
Profit After Adjustments	25	-8	29	65	36
Adjusted Earnings Per Share	18.3	-5.8	20.3	45.5	25.5

Growth Rates

#	1 Year	3 Year	5 Year	10 Year
Sales CAGR	22%	17%	0%	0%
Operating Profit CAGR	87%	25%	0%	0%
PAT CAGR	124%	38%	0%	0%

#	1 Year	3 Year	5 Year	10 Year
Share Price CAGR	113%	55%	30%	NA%
ROE Average	20%	9%	9%	9%
ROCE Average	27%	14%	13%	13%

Chemfab Alkalis Balance Sheet

#(Fig in Cr.)	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Shareholder's Funds	276	267	298	361
Minority's Interest	0	0	0	0
Borrowings	22	23	0	0
Other Non-Current Liabilities	-37	-10	-6	3
Total Current Liabilities	76	42	58	68
Total Liabilities	337	322	349	433
Fixed Assets	195	202	194	192
Other Non-Current Assets	64	44	56	95
Total Current Assets	78	76	89	141
Total Assets	337	322	349	433

Chemfab Alkalis Cash Flow

#(Fig in Cr.)	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Opening Cash & Cash Equivalents	1	0	23	33
Cash Flow from Operating Activities	54	45	55	93
Cash Flow from Investing Activities	-58	-6	-21	-48
Cash Flow from Financing Activities	3	-16	-25	-9
Net Cash Inflow / Outflow	-1	23	9	36
Closing Cash & Cash Equivalent	0	23	33	69

Chemfab Alkalis Ratios

#	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Earnings Per Share (Rs)	18.26	-5.78	20.34	45.54
CEPS(Rs)	36.27	8.6	36.06	61.71
DPS(Rs)	1.25	0	1.25	1.25
Book NAV/Share(Rs)	197.46	189.72	210.18	253.86
Core EBITDA Margin(%)	27.11	13.05	20.84	33.3
EBIT Margin(%)	14.8	2.65	14.78	27.07
Pre Tax Margin(%)	13.06	1.12	14.37	26.91
PAT Margin (%)	12.44	-4.5	10.56	19.43
Cash Profit Margin (%)	24.71	6.69	18.73	26.33
ROA(%)	7.56	-2.47	8.56	16.52
ROE(%)	9.25	-3	10.2	19.66
ROCE(%)	9.52	1.56	13.34	27.01
Receivable days	17.03	24.94	24.55	23.71
Inventory Days	15.17	17.96	14.17	15.8
Payable days	164.65	147.56	87.1	125.44
PER(x)	5.1	0	12.32	4.93
Price/Book(x)	0.47	0.66	1.19	0.88
Dividend Yield(%)	1.34	0	0.5	0.56
EV/Net Sales(x)	0.83	1.13	1.3	0.95
EV/Core EBITDA(x)	2.89	8.18	5.66	2.71
Net Sales Growth(%)	0	-11.59	50.21	22.01
EBIT Growth(%)	0	-84.15	738.77	123.64
PAT Growth(%)	0	-131.96	453.52	124.66
EPS Growth(%)	0	-131.67	451.69	123.9
Debt/Equity(x)	0.15	0.12	0.02	0
Current Ratio(x)	1.03	1.82	1.55	2.08
Quick Ratio(x)	0.92	1.6	1.34	1.83
Interest Cover(x)	8.52	1.73	35.85	173.69
Total Debt/Mcap(x)	0.33	0.17	0.02	0

Chemfab Alkalis Shareholding Pattern

#	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	73.7	73.36	73.35	73.35	73.3	73.11	73.11	72.99	72.88	72.88
FII	0.04	0.02	0	0.38	0.31	0.39	0.28	0.24	0.29	0.35
DII	0.08	0.08	0.08	0.08	0.08	0.08	0.08	0.08	0.1	0.1
Public	26.19	26.55	26.58	26.2	26.31	26.43	26.53	26.7	26.73	26.67
Others	0	0	0	0	0	0	0	0	0	0
Total	100	100	100	100	100	100	100	100	100	100

#	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	1.04	1.04	1.04	1.04	1.04	1.04	1.04	1.04	1.04	1.04
FII	0	0	0	0.01	0	0.01	0	0	0	0
DII	0	0	0	0	0	0	0	0	0	0
Public	0.37	0.38	0.38	0.37	0.37	0.37	0.38	0.38	0.38	0.38
Others	0	0	0	0	0	0	0	0	0	0
Total	1.41	1.41	1.41	1.41	1.41	1.42	1.42	1.42	1.42	1.42

Pros

Company is almost debt free.

Cons

Company has a low return on equity of 9% over the last 3 years.
Debtor days have increased from 87.1 to 125.44days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.